Assessing the Effects of HbA1c Reduction on Alleviating Nonspecific Back Pain

Diabetes Clinical Trial

Official title: Assessing the Effects of HbA1c Reduction on Alleviating Nonspecific Back Pain in Prediabetic Non-obese Patients: A Randomized Controlled Trial

Status Completed

Clinical Trial Summary

Prediabetes, characterized by elevated HbA1c levels, is a common precursor to type 2 diabetes mellitus. Recent studies have suggested a potential link between prediabetes and nonspecific back pain. This randomized controlled trial aimed to assess whether reducing HbA1c levels through lifestyle interventions and, along with the correction of vitamin D and magnesium, can alleviate nonspecific back pain in prediabetic patients.

Clinical Trial Description

The study included 40 patients from an outpatient clinic in Baghdad, evenly divided into intervention and control groups. The intervention group underwent a 6-month lifestyle modification program, focusing on diet, sleep, exercise, and vitamin D and magnesium correction. HbA1c levels were measured, and back pain severity was assessed (through what assessment method ?). The control group received standard care with NSAIDs and acetaminophen for pain management. Assessments were conducted at baseline and at various intervals over a total period of 6 months to evaluate changes in HbA1c levels and back pain intensity.

This randomized controlled trial provides evidence that reducing HbA1c levels through lifestyle modifications, along with the correction of vitamin D and magnesium, can lead to a reduction in nonspecific back pain intensity and improved functional outcomes in prediabetic patients. ;

Related Conditions & MeSH terms

• Back Pain
• Back Pain Lower Back Chronic
• Back Pain, Low
• Diabetes
• Diabetes Mellitus
• Low Back Pain
• Pre Diabetes
• Prediabetic State

• NCT number: NCT06064058
• Study type: Interventional
• Source: University of Baghdad
• Status: Completed
• Phase: N/A
• Start date: January 30, 2023
• Completion date: September 1, 2023